Titan Medical Inc (TMDIF)

[Md4Ob]

I suspect that SV Life Sciences will be buying both Transenterix and Titan (or either company) in the very near future. The assets will become private corporations and the products will be reintroduced for a public offering at a much higher cost. This is typical of private equity firms. The dream was nice while it lasted. Think about it. In a short time Transenterix reports that its Surgibot will experience a delayed release, Titan VIPs are all together and at the same time SV Life Sciences announces a stake in Xiomedica. Upon releasing its news Transenterix drops by only about 10% and not to a greater extent. Pure coincidence it is not. Titan will probably be sold within the next 30 days for $2.20/share, taken private and upon final approval be either the CE or FDA be offered as an IPO.